Overview

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this surveillance is to collect more safety and efficacy data in "non-study" patients during concomitant and adjuvant temozolomide therapy.

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Dacarbazine
Temozolomide